NPI registry status
Active
2026 NPPES data Medical Oncology Physician NPI 1942207337 MD
Verify on CMS → Narinder Malhotra, MD
Medical Oncology Physician in Meadville, Pennsylvania.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 3,815 in Medical Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
123
Medicare Part D claims · 31 beneficiaries · Medical Oncology Physician avg: 689
Generic prescribing
72%
generic claims · 28% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$43.28
2 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
Compiled from official public sources by the PlainDoctor editorial team.
What the federal data shows
Narinder Malhotra, MD filed 123 Medicare Part D claims in 2023 as a Medical Oncology Physician in Meadville, Pennsylvania, prescribing 72% generic.
- 123
- Part D claims, 2023
- 72%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Narinder Malhotra, MD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023, across all CMS prescribers nationally
123 35th percentile higher than 35% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
✓
Board certification likely (heuristic, not verified)
Narinder Malhotra, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Narinder Malhotra, MD?
Quality data not reportedPrimary specialty
Medical Oncology Physician
Medicare Part D claims
123 82% vs specialty avg
Specialty distribution in Pennsylvania
How Medical Oncology Physician compares to other specialties among Pennsylvania providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Medical Oncology Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Narinder Malhotra, MD appears in the CMS NPPES registry as a Medical Oncology Physician provider holding MD credentials at 16792 CONNEAUT LAKE RD, Meadville, PA, 16335, with a listed phone of (814) 373-2335. NPI 1942207337 was issued on 06/30/2005.
Medicare Part D records for calendar year 2023 show 123 prescription claims written by this provider, covering 31 Medicare beneficiaries and totaling roughly $518K in drug spend, split 28% brand-name and 72% generic by claim count.
Medical Oncology Physician is a narrow specialty nationwide, with 3,815 enrolled providers across 53 states and an average of 689 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1942207337 |
|---|---|
| Specialty | Medical Oncology Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 06/30/2005 |
Hospital and facility affiliations
Facilities where Narinder Malhotra, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Meadville Medical Center
★★★★☆ 4/5
Meadville, PA
Acute Care Hospitals
CMS CCN: 390113
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Narinder Malhotra, MD. Source: openpaymentsdata.cms.gov.
Total received
$43
Largest payer
AstraZeneca Pharmaceuticals LP
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Pennsylvania PA-BOM 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~45K Pennsylvania medical licensees in 2023 - they are NOT specific to Narinder Malhotra, MD. To verify Narinder Malhotra, MD's current license status, search the PA-BOM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
133
Total board actions, Pennsylvania 2023
Across 129 cases
2.96
Actions per 1,000 licensees
Pennsylvania statewide rate
probation
Most common action type
48 cases
PA-BOM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Pennsylvania disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Above average
Narinder Malhotra, MD - brand share 28.0%
Medical Oncology Physician average
28% brand-name claims vs 72% generic, on 123 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
123
Total Claims
$518K
Total Drug Cost
31
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 156
- Total Day Supply
- 4,405
- Brand vs Generic
- 28% brand / 72% generic
- Brand Drug Cost
- $468K
- Generic Drug Cost
- $50K
Patient Demographics
- Average Patient Age
- 69.7 years
- Avg HCC Risk Score
- 2.11
- Gender Split
- 52% female / 48% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Narinder Malhotra, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Hydroxyurea
Hydroxyurea
24 claims
- Buprenorphine Hcl
Buprenorphine Hcl
17 claims
- Ibrance
Ibrance
13 claims
- Sprycel
Sprycel
13 claims
- Imatinib Mesylate
Imatinib Mesylate
12 claims
| Drug | Claims |
|---|---|
| Hydroxyurea | 24 |
| Buprenorphine Hcl | 17 |
| Ibrance Palbociclib | 13 |
| Sprycel Dasatinib | 13 |
| Imatinib Mesylate | 12 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Medical Oncology Physician Overview
How Narinder Malhotra, MD fits within the Medical Oncology Physician landscape nationally.
3,815
Medical Oncology Physician Providers in US
53
States with Medical Oncology Physician
689
Avg Claims per Provider
Narinder Malhotra, MD's 123 claims are below the specialty average of 689.
Nearby Medical Oncology Physician Providers in Pennsylvania
Other clinicians with the same primary specialty enrolled in Pennsylvania, drawn from the same CMS NPPES roster as Malhotra.
Dr. Maysa Abu-Khalaf
MD
Philadelphia, PA
Dr. Sramila Aithal
MD
Bensalem, PA
Dr. Heidar Albandar
MD
Fountain Hill, PA
Dr. Seyfettin Alpdogan
MD
Philadelphia, PA
Dr. Fern Anari
M.D.
Philadelphia, PA
Compare Medical Oncology Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Pennsylvania medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Medical Oncology Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore Pennsylvania
Frequently Asked Questions
What is Narinder Malhotra, MD's specialty? ▼
Narinder Malhotra, MD specializes in Medical Oncology Physician and practices in Meadville, Pennsylvania. Credentials: MD.
How much does Narinder Malhotra, MD prescribe under Medicare Part D? ▼
In 2023, Narinder Malhotra, MD wrote 123 Medicare Part D claims totaling $518K in drug costs for 31 beneficiaries.
Where is Narinder Malhotra, MD located? ▼
Narinder Malhotra, MD is located at 16792 CONNEAUT LAKE RD, Meadville, PA, 16335. Phone: (814) 373-2335.
What is Narinder Malhotra, MD's NPI number? ▼
Narinder Malhotra, MD's National Provider Identifier (NPI) is 1942207337, issued on 06/30/2005.
Does Narinder Malhotra, MD prescribe more brand-name or generic drugs? ▼
Narinder Malhotra, MD's prescribing is 28% brand-name and 72% generic drugs by claim count, with $468K in brand drug costs.
How many Medical Oncology Physician providers are there in the US? ▼
There are 3,815 Medical Oncology Physician providers across 53 states in the US. The average Medical Oncology Physician provider writes 689 Medicare Part D claims per year.
What drugs does Narinder Malhotra, MD prescribe most often? ▼
Based on 2023 Medicare Part D data, Narinder Malhotra, MD's most frequently prescribed drugs include Hydroxyurea, Buprenorphine Hcl, Ibrance. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Narinder Malhotra, MD accept Medicare? ▼
Narinder Malhotra, MD appears in CMS Medicare data with 123 Part D claims and 31 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Narinder Malhotra, MD's credentials? ▼
Narinder Malhotra, MD's NPI is 1942207337 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Compiled from official public sources by the PlainDoctor editorial team.
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.